Journal List > J Korean Diabetes > v.12(2) > 1054773

Ju: Vitamin D and Diabetes

Abstract

Epidemiologic evidence suggests that vitamin D status, as assessed by serum 25-hydroxyvitamin D levels, is associated with increased risk for diabetes, and that adequate intake of vitamin D may prevent or delay the onset of diabetes. Many individuals with diabetes have decreased levels of vitamin D, and lack of vitamin D may be associated with hyperglycemia, increased hemoglobin A1c, insulin resistance, and progression of diabetes. Optimal vitamin D status is needed to prevent adverse outcomes in diabetic patients. Increasing intake of vitamin D by diet, oral supplements and sun exposure may be easy and cost-effective methods to improve metabolic control and prevent diabetes.

REFERENCES

1. Zhang R, Naughton DP. Vitamin D in health and disease: current perspectives. Nutr J. 2010; 9:65.
crossref
2. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clin Proc. 2011; 86:50–60.
crossref
3. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of vitamin D and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab. 2007; 92:2017–29.
crossref
4. Zipitis CS, Akobeng AK. Vitamin D supplementation in early childhood and risk of type 1 diabetes: a systematic review and meta-analysis. Arch Dis Child. 2008; 93:512–7.
crossref
5. Hyppönen E, Läärä E, Reunanen A, Järvelin MR, Virtanen SM. Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study. Lancet. 2001; 358:1500–3.
crossref
6. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care. 2007; 30:980–6.
crossref
7. Holick MF, Chen TC. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87:1080S–6S.
crossref
8. Kennel KA, Drake MT, Hurley DL. Vitamin D deficiency in adults: when to test and how to treat. Mayo Clin Proc. 2010; 85:752–7.
crossref
9. Ginde AA, Liu MC, Camargo CA Jr. Demographic differences and trends of vitamin D insufficiency in the US population, 1988-2004. Arch Intern Med. 2009; 169:626–32.
crossref
10. Thacher TD, Fischer PR, Strand MA, Pettifor JM. Nutritional rickets around the world: causes and future directions. Ann Trop Paediatr. 2006; 26:1–16.
crossref
11. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357:266–81.
crossref
12. Bischoff-Ferrari HA, Giovannucci E, Willett WC, Dietrich T, Dawson-Hughes B. Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes. Am J Clin Nutr. 2006; 84:18–28.
crossref
13. The Korean Nutrition Society. Dietary reference intakes for Koreans. First revision. Seoul: Hanareum Plannling;2010.
14. Ministry for Health, Welfare and Family Affairs & Korean Centers for Disease Controls and Prevention. Korea Health Statistics 2009 - Korea National Health and Nutrition Examination Survey(KNHANES Ⅳ-3). 2010. 64. 526.
15. Mohr SB, Garland CF, Gorham ED, Garland FC. The association between ultraviolet B irradiance, vitamin D status and incidence rates of type 1 diabetes in 51 regions worldwide. Diabetologia. 2008; 51:1391–8.
crossref
16. Pittas AG, Dawson-Hughes B, Li T, Van Dam RM, Willett WC, Manson JE, Hu FB. Vitamin D and calcium intake in relation to type 2 diabetes in women. Diabetes Care. 2006; 29:650–6.
crossref
17. Hollis BW. Circulating 25-hydroxyvitamin D levels indicative of vitamin Dsufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr. 2005; 135:317–22.
18. Vieth R, Bischoff-Ferrari H, Boucher BJ, Dawson-Hughes B, Garland CF, Heaney RP, Holick MF, Hollis BW, Lamberg-Allardt C, McGrath JJ, Norman AW, Scragg R, Whiting SJ, Willett WC, Zittermann A. The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr. 2007; 85:649–50.
crossref
19. Choi YM, Lee JH, Han JS. Effects of vitamin d and calcium intervention on the improvement of resistance in patients with type 2 diabetes mellitus. Korean Diabetes J. 2009; 33:324–34.
crossref

Fig. 1.
Vitamin D metabolism. Ca, calcium; 1,25(OH)2D, 1,25-dihydroxyvitamin D; 25(OH)D, 25-hydroxyvitamin D; PTH, parathyroid hormone.
jkd-12-104f1.tif
Table 1.
Applications for vitamin D testing
Clinical risk factors for vitamin D deficiency
Decreased intake Inadequate oral intake
Malnutrition (poor oral intake)
Limited sun exposure
Gastrointestinal malabsorption Short bowel syndrome
Pancreatitis
Inflammatory bowel disease
Amyloidosis
Celiac sprue
Malabsorptive bariatric surgery procedures
Hepatic Some antiepileptic medication (increased 24-hydroxylase activity)
Severe liver disease or failure (decreased 25-hydroxylase activity)
Renal Aging (decreased 1-α hydroxylase activity)
Renal insufficiency, glomerular filtration rate < 60% (decreased 1-α hydroxylase activity)
Nephrotic syndrome (decreased levels of vitamin D-binding protein)
Laboratory and radiographic findings that suggest possible vitamin D deficiency
Laboratory Low 24-hour urine calcium excretion (in the absence of thiazide use)
Elevated parathyroid hormone level
Elevated total or bone alkaline phosphatase level
Low serum calcium and/or serum phosphate level
Radiographic Decreased bone mineral density (osteopenia or osteoporosis)
Nontraumatic (fragility) fracture
Skeletal pseudofracture
TOOLS
Similar articles